Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | PDXK | O00764 | 2/20 | 0.35 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9348818 | 0.85 | MEN1 (0.41) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL7185587 | 0.79 | MEN1 (0.43) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL10624689 | 0.79 | KMT2A (0.42) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL11792430 | 0.74 | MEN1 (0.39) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL11836721 | 0.74 | MEN1 (0.39) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL11246327 | 0.74 | GABRA1 (0.44) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL9338760 | 0.73 | DHFR (0.42) | MEN1KMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL28585139 | 0.73 | SHBG (0.42) | MEN1KMT2APTGS1PTGS2GAA | |
| SCHEMBL10949085 | 0.72 | XDH (0.39) | MEN1KMT2AALOX5PTGS1GAA | |
| SCHEMBL9332613 | 0.71 | GAA (0.53) | MEN1KMT2AALOX5PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. | 2009-08-13 | — | — | US | disclosed |
| US-3998863-A | ANTIOXIDANTS | AMERICAN CYANAMID COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | SMCHD1, SMC1A, SI | MEN1 735/4885KMT2A 4652/4885ALOX5 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.